National and Kapodistrian University of Athens
Ο ρόλος των υποδοχέων των οιστρογόνων (ER-a / ER-b) και γλυκοκορτικοειδών (GR) στην παθοφυσιολογία του προστάτη και της βιολογίας της κυτταρικής σειράς PC-3
Abstract
dc:descriptionTill today we don’t know exactly the pathogenesis of prostate cancer. Even that glucocorticoids prevent in vivo and in vitro the evolution of certain normal cell lines or modified cell lines, so little are known about the mechanism of this cell respond (132,133). Though it is certain that estrogen (ER-a, ER-b) and glucocorticoid (GR) receptors exist in cell nucleus of prostate and that are activated by small lipofilic molecules like glucocorticoids, progesterone, estrogen, retinoids and fatty acid derivatives. Recent studies establish the existence of 2 estrogen receptors in the stroma and epithelium of prostate (240). These studies show low expression of ER-b in prostate cancer cells versus normal cells, where the ER-a receptor is dominant (239). The conclusion is that ER-b may have a protective role in prostate cancer. A whole new research area is produced about hormone therapy (chemoprofilaxis with SERMs - selective estrogen receptor modulators, acapodene, arzoxifene, 240). The therapeutic management of prostate cancer is a grate challenge, especially with patients that even their initial response in therapy with androgenic exclusion; they toggle in the ormone resistant stage of the disease (stage D3). This stage has a very bad prognosis. The mean survival of patients with stage D3 prostate cancer is between 9 to 12 months. We designed this study in order to investigate the expression and role of glucocorticoid and estrogen receptors in prostate cancer. The PC-3 cell line was used, which resembles prostate cancer cells and is used widely as an in vitro model. Specifically we investigate the presence and effectiveness of GR in metastatic PC-3 cells of prostate cancer and we tested its function in the regulation of PC-3 cell proliferation through the expression of TGF β1. Our results record the presence of pure GR in PC-3 cells and that dexamethasone inhibits the G1/G0 mitosis stage. Further dexamethasone and TGF β1 inhibit the proliferation of PC-3 cells, the polyclonic antibody anti-TGF β1 blokes the inhibition of dexamethasone, the PDGF excites the proliferation of PC-3 cells and compensates the inhibition of dexamethasone in PC-3 cell lines and finally that dexamethasone modifies positively the expression of TGF β1 mRNA in PC-3 cells. We conclude that: a) the pure functional GR factor is present in PC-3 cells, b) the function of GR is mediated by the translation of TGF β1 in PC-3 cells, c) the interactions of GR function with factors like TGF β1 and PDGF could affect the growth and maybe the metastatic ability of prostate cancer cells, as example PC-3 cells. Consequently, the molecular action of dexamethasone in osteoblasts, in prostate cancer cells and their intracellular actions, highlights the therapeutic indication of using glucocorticoids, in bone metastasis especially, of prostate cancer (122, 123, 124, 125). We point to a new perception of combined therapy, that will conclude ASF and an anticancer therapy. The ability of an ASF therapy to introduce clinical responses (decrease of PSA below 4.0 ng/ml), in patients with stage D3 prostate cancer, in whom the chemotherapy was failed, would be very encouraging.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Δημόπουλος, Αντώνιος
Subjects
dc:subject × 18- Καρκίνος προστάτη
- Υποδοχείς γλυκοκορτικοειδών
- Κυτταρική σειρά PC-3 καρκίνου προστάτη
- Υποδοχείς οιστρογόνων
- Ρόλος του TGFb1 στα PC-3
- Έκφραση TGFb1 στα PC-3
- Δράση γλυκοκορτικοειδών στα κύτταρα PC-3
- Prostate cancer
- Glucocorticoid receptors
- Prostate cancer cell line PC-3
- Estrogen receptors
- Role of TGFb1 in cell line PC-3
- Expression of TGFb1 in PC-3
- Role of gluocorticoids in cell line PC-3
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23655